glp-1/gip receptor agonists Possible mechanisms of the interaction of GIP and GLP-1 for treatment The Clinical Application of GLP-1RAs
Description
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
Methodology This KFF Health Tracking Poll/Health Misinformation Tracking Poll was designed and analyzed by public opinion researchers at KFF
Pricing is competitive with mid-tier providers
Most patients tolerate the medications well after the initial adjustment period
doi: 10.1016/S0140-6736(14)61393-3 56 ArmstrongMJOkunMS
